SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-17-000604
Filing Date
2017-06-16
Accepted
2017-06-16 09:08:06
Documents
2
Period of Report
2017-06-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT brownlie_fm3jun152017.html 3  
1 OWNERSHIP DOCUMENT brownlie_fm3jun152017.xml 3 1565
2 poa_brownlie.htm EX-24 5339
  Complete submission text file 0000905718-17-000604.txt   8485
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591
Business Address
Brownlie Keith L (Reporting) CIK: 0001518575 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15006 | Film No.: 17914878